Presentation is loading. Please wait.

Presentation is loading. Please wait.

by Wendy Lim, Sara K. Vesely, and James N. George

Similar presentations


Presentation on theme: "by Wendy Lim, Sara K. Vesely, and James N. George"— Presentation transcript:

1 by Wendy Lim, Sara K. Vesely, and James N. George
The role of rituximab in the management of patients with acquired thrombotic thrombocytopenic purpura by Wendy Lim, Sara K. Vesely, and James N. George Blood Volume 125(10): March 5, 2015 ©2015 by American Society of Hematology

2 Literature search data
Literature search data. *One article included 2 case series: one case series of patients receiving initial treatment with rituximab and another case series of asymptomatic patients receiving rituximab prophylaxis. Literature search data. *One article included 2 case series: one case series of patients receiving initial treatment with rituximab and another case series of asymptomatic patients receiving rituximab prophylaxis. Wendy Lim et al. Blood 2015;125: ©2015 by American Society of Hematology

3 Rituximab for the treatment of patients with TTP and for treatment of ADAMTS13 deficiency during remission: studies with a comparison group. Rituximab for the treatment of patients with TTP and for treatment of ADAMTS13 deficiency during remission: studies with a comparison group Wendy Lim et al. Blood 2015;125: ©2015 by American Society of Hematology


Download ppt "by Wendy Lim, Sara K. Vesely, and James N. George"

Similar presentations


Ads by Google